ESTIMATED
04/10/2024
04/10/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.12 | -$0.12 | -$0.12 |
Q2 2024 | 3 | -$0.02 | -$0.02 | -$0.02 |
Q3 2024 | 0 | $0.03 | $0.03 | $0.03 |
Q4 2024 | 0 | $0.08 | $0.08 | $0.08 |
Q1 2025 | 1 | $0.01 | $0.01 | $0.01 |
Q2 2025 | 1 | $0.05 | $0.05 | $0.05 |
Q3 2025 | 1 | $0.03 | $0.03 | $0.03 |
Q4 2025 | 1 | $0.06 | $0.06 | $0.06 |
Theratechnologies Inc. last posted its earnings results on Wednesday, April 10th, 2024. The company reported $-0.1 earnings per share for the quarter, topping analysts' consensus estimates of $-0.12 by $0.02. The company had revenue of 16.09 M for the quarter and had revenue of 81.76 M for the year. Theratechnologies Inc. has generated $-1 earnings per share over the last year ($-0.91 diluted earnings per share) and currently has a price-to-earnings ratio of -3.57. Theratechnologies Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 10th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 04/10/2024 | Q1 2024 | -$0.12 | -$0.10 | 0.02 | $20.09 M | $16.09 M | 02/21/2024 | Q4 2023 | -$0.24 | -$0.08 | 0.16 | $23.45 M | 09/26/2023 | Q3 2023 | -$0.29 | -$0.03 | 0.26 | $20.86 M | 07/12/2023 | Q2 2023 | -$0.10 | -$0.41 | -0.31 | $17.55 M | 04/12/2023 | Q1 2023 | -$0.38 | -$0.43 | -0.05 | $21.66 M | $19.91 M | 11/30/2022 | Q4 2022 | -$0.33 | $21.42 M | 10/13/2022 | Q3 2022 | -$0.12 | -$0.32 | -0.2 | $20.81 M | 07/14/2022 | Q2 2022 | -$0.38 | -$0.96 | -0.58 | $19.27 M | 04/13/2022 | Q1 2022 | -$0.07 | -$0.38 | -0.31 | $21.50 M | $18.56 M | 11/30/2021 | Q4 2021 | -$0.42 | $20.50 M | $18.75 M | 10/13/2021 | Q3 2021 | -$0.07 | -$0.40 | -0.33 | $17.85 M | 07/15/2021 | Q2 2021 | -$0.07 | -$0.27 | -0.2 | $17.79 M | 04/14/2021 | Q1 2021 | -$0.05 | -$0.28 | -0.23 | $19.50 M | $15.43 M | 11/30/2020 | Q4 2020 | -$0.28 | $18.33 M | $19.12 M | 10/15/2020 | Q3 2020 | -$0.06 | -$0.35 | -0.29 | $14.05 M | 07/15/2020 | Q2 2020 | -$0.05 | -$0.30 | -0.25 | $17.16 M | 04/14/2020 | Q1 2020 | -$0.02 | -$0.24 | -0.22 | $19.70 M | $15.72 M | 11/30/2019 | Q4 2019 | -$0.34 | $17.12 M | $16.40 M | 10/08/2019 | Q3 2019 | -$0.02 | -$0.09 | -0.07 | $16.11 M | 05/31/2019 | Q2 2019 | -$0.17 | $15.61 M |
---|
A. Theratechnologies Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 10th, 2024 based off last year's report dates.
A. In the previous quarter, Theratechnologies Inc. (NASDAQ:THTX) reported $-0.1 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.12 by $0.02.
A. The conference call for Theratechnologies Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Theratechnologies Inc.'s latest earnings report can be read online.
A. Theratechnologies Inc. (NASDAQ:THTX) has a recorded annual revenue of $81.76 M.
A. Theratechnologies Inc. (NASDAQ:THTX) has a recorded net income of $81.76 M. Theratechnologies Inc. has generated $-0.91 earnings per share over the last four quarters.
A. Theratechnologies Inc. (NASDAQ:THTX) has a price-to-earnings ratio of -3.57 and price/earnings-to-growth ratio is -0.53.